{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:06:45Z","timestamp":1793639205942,"version":"4.5.1"},"posted":{"date-parts":[[2025,4,22]]},"group-title":"In Review","reference-count":6,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006732","name":"New York University","doi-asserted-by":"publisher","award":["S10OD030282"],"award-info":[{"award-number":["S10OD030282"]}],"id":[{"id":"10.13039\/100006732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,4,17]]},"abstract":"<title>Abstract<\/title>\n        <p>Xenotransplantation of pig organs is a promising solution to the organ shortage; however, rejection remains a major obstacle. Pig-to-human decedent transplantation provides an opportunity to study immune barriers to xenotransplantation experimentally. We tracked donor-reactive T cell dynamics in a 61-day pig-to-human decedent thymokidney xenotransplant. Xenogeneic donor-reactive T cell clones (XDRTCCs) identified using high-throughput <italic>TCRB<\/italic> CDR3 sequencing expanded markedly in peripheral blood in association with apparent antibody-mediated rejection (AMR). Single-cell RNA and TCR sequencing of leukocytes from the xenograft showed XDRTCC infiltration and effector transcript expression during AMR. Additionally, \u03b3\u03b4 and NK cells with cytotoxic effector phenotypes were prominent in the rejecting xenograft. These data suggest that improved suppression of innate immunity and T cell responses might enhance the success of xenotransplantation.<\/p>","DOI":"10.21203\/rs.3.rs-6474835\/v1","type":"posted-content","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T06:19:10Z","timestamp":1745302750000},"source":"Crossref","is-referenced-by-count":5,"title":["Donor-reactive T cells and innate immune cells promote pig-to-human decedent xenograft rejection"],"prefix":"10.21203","author":[{"given":"Farshid","family":"Fathi","sequence":"first","affiliation":[{"name":"Department of Medicine, Columbia Center for Translational Immunology, Columbia University Medical Center, Columbia University; New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Suek","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia Center for Translational Immunology, Columbia University Medical Center, Columbia University; New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Vermette","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia Center for Translational Immunology, Columbia University Medical Center, Columbia University; New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Breen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia Center for Translational Immunology, Columbia University Medical Center, Columbia University; New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmeen S.","family":"Saad","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia Center for Translational Immunology, Columbia University Medical Center, Columbia University; New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanza","family":"Bay","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia Center for Translational Immunology, Columbia University Medical Center, Columbia University; New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Parks","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia Center for Translational Immunology, Columbia University Medical Center, Columbia University; New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Stern","sequence":"additional","affiliation":[{"name":"Department of Surgery, Transplant Institute, New York University Langone Health; New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Khalil","sequence":"additional","affiliation":[{"name":"Department of Surgery, Transplant Institute, New York University Langone Health; New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Surgery, Transplant Institute, New York University Langone Health; New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian S.","family":"Jaffe","sequence":"additional","affiliation":[{"name":"Department of Surgery, Transplant Institute, New York University Langone Health; New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad","family":"Aljabban","sequence":"additional","affiliation":[{"name":"Department of Surgery, Transplant Institute, New York University Langone Health; New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Novikova","sequence":"additional","affiliation":[{"name":"Department of Medicine, NYU Grossman School of Medicine; New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Severa","sequence":"additional","affiliation":[{"name":"Department of Medicine, NYU Grossman School of Medicine; New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin Sedaghat","family":"Herati","sequence":"additional","affiliation":[{"name":"Department of Medicine, NYU Grossman School of Medicine; New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Burdorf","sequence":"additional","affiliation":[{"name":"United Therapeutics Corporation; Research Triangle Park, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Adam D. Griesemer2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Montgomery","sequence":"additional","affiliation":[{"name":"Department of Surgery, Transplant Institute, New York University Langone Health; New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Sykes","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia Center for Translational Immunology, Columbia University Medical Center, Columbia University; New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Figure 1 Characterization of healthy donor indirectly and directly xenoreactive T cell repertoire in vitro. (A, upper panel) Method for direct xenogeneic mixed lymphocyte reaction (MLR). Porcine DC are co-cultured with CFSE-labeled purified human T cells. After 6 days, proliferated T cells, identified as CFSElow, are sorted by flow cytometry, genomic DNA is extracted, and high throughput TCRB CD3 sequencing is carried out. (A, lower panel) Method for indirect xenogeneic MLR. Pig PBMCs are irradiated with 100 Gy to induce apoptosis and loaded into differentiated, sorted human macrophages. Loaded macrophages are MACS sorted for CD14 expression and combined with CFSE-labeled purified T cells. Proliferated CFSElow T cells are sorted by flow cytometry, genomic DNA is extracted, and high throughput TCRB CDR3 sequencing is carried out. (B) Direct and Indirect MLRs induce proliferation of both CD4 and CD8 cells. (C) Clonal frequency plots of divided T cells following high-throughput TCR sequencing of the CD4 and CD8 response to indirect (y axis) and direct (x axis) stimulation by porcine antigens. Clonotypes that are unique to one pathway appear along the y or x axis (for indirect and direct respectively). Clonotypes found in both sequence sets are depicted within the yellow-shaded area"},{"key":"ref2","unstructured":"Figure 2: Overview of long-term thymokidney xenotransplant, sampling, and TCRB CDR3 sequencing of peripheral blood T cell DNA over time (A) Schematic overview of the xenotransplantation experiment. Blood, kidney, and lymphocele samples were obtained from the decedent human and source pig pre- and post-transplantation. T cells were sorted from unstimulated (unstim) populations or from CFSElow cells in MLRs. (B) Clonal expansion of circulating CD4 and CD8 T cells over time. CD4 and CD8 T cells were not separated in pre-transplant FACS sort. Fisher\u2019s exact test was used to compare proportion of hyperexpanded clones compared to pre-Tx baseline, ****P\u2009<\u20090.0001 (C) Cumulative frequency of clones shared between timepoints. The reference population on the x-axis is the population whose cumulative frequency is plotted, and the overlap frequency is shown for the populations on the y-axis. The pre-transplant repertoire has been included by estimating the number of CD4 and CD8 templates using flow cytometric data (Extended Data Fig. 10C). (D) Frequency of the top 5 CD8 clones from every sequenced post-operative timepoints. Each color represents the frequency of a specific clonotype at that timepoint. Pre-transplant frequencies were determined by normalizing the frequency of individual CD8 clones within the CD3\u207a pre-transplant population to the proportion of CD8\u207a cells within the CD3\u207a gate as determined by flow cytometry (Extended Data Fig. 10C). Some of the top 5 clonotypes are shared across the timepoints, resulting in fewer than 15 unique clones"},{"key":"ref3","author":"Figure 3","unstructured":"Figure 3, CD8 (B XDRTCCs demonstrate selective expansion and enrichment in the blood over time. (A, B) Cumulative frequency of CD4 (A) and) XDRTCCs and non-XDRTCCs at each timepoint. Pre-transplant frequencies were determined by normalizing the frequency of individual CD4 and CD8 clones within the CD3\u207a pre-transplant population to the proportion of CD4+ and CD8\u207a cells within the CD3\u207a gate, respectively, as determined by flow cytometry (Extended Data Fig. 10C). (C) Designation of the top 5 expanded CD8 clones (see Fig. 2D) according to XDRTCC or non-XDRTCC status at each timepoint post-transplant. (D) Cumulative frequency fold change of both CD4 and CD8 post-transplant XDRTCCs as normalized to their pre-transplant baseline. The formula is shown. (E) Relative clonal detection rate of both CD4 and CD8 XDRTCCs compared to non-XDRTCCs identified pre-transplant. The formula is shown. (F) Relative template detection rate of both CD4 and CD8 XDRTCCs compared to non-XDRTCCs identified pre-transplant. The formula is shown. For Figures D, E and F, a dotted line is plotted at y\u2009=\u20091 to represent the cutoff between XDRTCC enrichment (>\u20091) or depletion (<\u20091). The statistics establish significance between the numerator and denominator in every case (post-transplant to pre-transplant XDRTCC cumulative frequency for Figure D, and XDRTCC to non-XDRTCC enrichment for Figures E and F). *P\u2009<\u20090.05, ** P\u2009<\u20090.01, ***P\u2009<\u20090.001, ****P\u2009<\u20090.0001, by Z test"},{"key":"ref4","unstructured":"Figure 4 Single-cell RNA sequencing of xenograft leukocytes demonstrates upregulation of cytotoxic populations during rejection. (A) Integrated UMAP showing single-cell RNA sequencing results on hCD45+ sorted cells from POD14 kidney biopsy (POD14K), POD14 lymphocele (POD14L), POD28 kidney biopsy (POD28K), POD33 kidney biopsy (POD33K), and POD61 kidney biopsy (POD61K). Cluster numbering is color-coded. When split by POD, specific clusters predominate in specific samples. For example, Clusters 0, 1, 6 and 9 are primarily found in POD14L, whereas Clusters 2, 3, 4, 5, and 12 are predominantly found in the POD33 kidney specimen. (B) Expression of T cell, effector T and NK cell, NK cell, and APC-associated RNA species in each cluster and specimen in panel A"},{"key":"ref5","unstructured":"Figure 5 XDRTCCs demonstrate a cytotoxic phenotype, particularly during rejection at POD33. (A) Distribution of XDRTCCs (red) across POD14K, POD14L, POD28K, POD33K, and POD61K samples demonstrates that the majority are found in POD14L and POD33K samples. (B, C) Differential gene expression in clusters 3 and 5, containing the most XDRTCCs, demonstrates upregulation of effector cell-associated genes in both clusters 3 (GZMB, GZMH, FASLG) and 5 (GZMK, CCL5, EOMES, CXCR3). In addition, Cluster 3 demonstrates upregulation of \u03b3\u03b4 T cell genes TRGV9, TRGC, and NK cell-associated gene NCR3, whereas Cluster 5 demonstrates upregulation of adaptive T cell genes including CD8B and TRBC2. (D) KEGG pathway analysis of the top differentially expressed genes demonstrate NK cell-mediated cytotoxicity as the top pathway for Cluster 3"},{"key":"ref6","author":"Figure 6","unstructured":"Figure 6 During rejection, \u03b3\u03b4 T cells and NK cells are found at high levels and express cytotoxic RNA profiles (A) Cluster 3 (see Fig. 5A) was subset and re-clustered to examine additional heterogeneity, separating out into 6 clusters (B) XDRTCCs are found in Clusters 0, 2, and 5. XDRTCCs with identical clonotypes are annotated with identical color bars above the cluster identity metadata. Clusters containing XDRTCCs express some cytotoxic genes, though to a lesser extent than Clusters 1, 3, 4, and 6. These other clusters also express high levels of \u03b3\u03b4 T cell and NK cell-associated genes. (C) \u03b1\u03b2 T cells segregate out from \u03b3\u03b4 and NK cells which co-cluster. (D) Clusters 1, 3, 4, and 6 containing \u03b3\u03b4 and NK cells demonstrate higher levels of activation and cytotoxic genes than Clusters 0, 2, and 4 containing XDRTCCs. (E) Macrophages and DCs are predicted to interact with T cells by TIGIT, causing suppression, but NK and \u03b3\u03b4 T cells are predicted to interact via CD226, causing activation. *P\u2009<\u20090.05, ** P\u2009<\u20090.01, ***P\u2009<\u20090.001, ****P\u2009<\u20090.0001, by Wilcoxon Rank Sum test"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6474835\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6474835\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T06:19:10Z","timestamp":1745302750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6474835\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":6,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-6474835\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,4,22]]},"subtype":"preprint"}}